These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18089782)

  • 21. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.
    Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY; Gao DM
    Clin Cancer Res; 2011 Aug; 17(16):5463-72. PubMed ID: 21712445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter-based mouse models of digestive system carcinogenesis.
    Rogers AB; Houghton J
    Methods Mol Biol; 2009; 511():267-95. PubMed ID: 19347301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
    Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
    Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex-based molecular profiling of hepatitis C virus-related hepatocellular carcinoma.
    Takemoto N; Iizuka N; Yamada-Okabe H; Hamada K; Tamesa T; Okada T; Hashimoto K; Sakamoto K; Takashima M; Miyamoto T; Uchimura S; Hamamoto Y; Oka M
    Int J Oncol; 2005 Mar; 26(3):673-8. PubMed ID: 15703822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinoma.
    Kittaka N; Takemasa I; Seno S; Takeda Y; Kobayashi S; Marubashi S; Dono K; Umeshita K; Nagano H; Matsuda H; Monden M; Mori M; Doki Y
    Ann Surg Oncol; 2010 Dec; 17(12):3145-54. PubMed ID: 20625842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of mouse hepatitis virus infection in gamma interferon-deficient mice is modulated by co-infection with Helicobacter hepaticus.
    Compton SR; Ball-Goodrich LJ; Zeiss CJ; Johnson LK; Johnson EA; Macy JD
    Comp Med; 2003 Apr; 53(2):197-206. PubMed ID: 12784855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early molecular and genetic determinants of primary liver malignancy.
    Feitelson MA; Pan J; Lian Z
    Surg Clin North Am; 2004 Apr; 84(2):339-54. PubMed ID: 15062649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlative analysis of histological profile of the adjoining liver parenchyma with liver enzyme levels in hepatocellular carcinoma and their comparison with chronic liver disease in autopsy cases.
    Vaiphei K
    Indian J Pathol Microbiol; 2007 Oct; 50(4):711-7. PubMed ID: 18306534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species.
    Ward JM; Fox JG; Anver MR; Haines DC; George CV; Collins MJ; Gorelick PL; Nagashima K; Gonda MA; Gilden RV
    J Natl Cancer Inst; 1994 Aug; 86(16):1222-7. PubMed ID: 8040890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GB virus C/hepatitis G virus infection among patients with hepatocellular carcinoma in the inshore area of the Yangtze River, China.
    Cao K; Mizokami M; Orito E; Ding X; Ueda R; Chen G; Yu SZ; Tokudome S
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1241-8. PubMed ID: 9918433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.
    Ringelhan M; Heikenwalder M; Protzer U
    Dig Dis; 2013; 31(1):138-51. PubMed ID: 23797136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.
    Kao JH; Chen PJ; Chen DS
    Adv Cancer Res; 2010; 108():21-72. PubMed ID: 21034965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
    J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
    Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
    Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.
    Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H
    Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.